Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race
Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...
China bans imports of Illumina's gene sequencers right after Trump tariff action
China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...
Insider Monkey14d
What Makes Illumina (ILMN) an Attractive Opportunity?
In its fourth quarter 2024 investor letter, Brown Advisors Global Leaders Strategy emphasized stocks such as Illumina, Inc. (NASDAQ:ILMN). Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array ...
Yahoo Finance15d
Illumina, Inc. (ILMN)
Investing.com -- HSBC downgraded Illumina Inc (NASDAQ:ILMN) to “Hold” from “Buy” and slashed its price target to $100 from $190, citing new headwinds from China, potential U.S. research funding cuts, ...
Case Western Reserve University17d
Next Generation Sequencing Services
The NovaSeq X Plus instrument is now available and ready for submissions! The 2-channel chemistry, patterned flow-cells are best for large scale genomic, epigenomic, and transcriptome sequencing. With ...
Case Western Reserve University17d
Our Services
The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...
Medical Device Network18d
Illumina’s spatial transcriptomics to accelerate breakthroughs in biomedical science
The system is fully compatible with Illumina’s NextSeq and NovaSeq sequencers, making high-resolution spatial research more cost-effective and accessible for single-cell and spatial researchers. To ...
Pharmabiz18d
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions
The combination of Illumina's Single Cell Prep, NovaSeq X Plus platform, 25B flow cell and DRAGEN analysis software creates a seamless end-to-end workflow enabling the high-throughput processing of ...
Pharmabiz21d
Illumina unveils first-of-its-kind spatial transcriptomics technology
The spatial solution surpasses industry standards for scale and accuracy, and is compatible with Illumina NextSeq and NovaSeq sequencers, thereby materially reducing the cost of running large-scale ...
Investing21d
Illumina and Broad Clinical Labs enhance single-cell research
The collaboration combines Illumina's Single Cell Prep and NovaSeq™ X Plus platform with Broad Clinical Labs' expertise in high-throughput workflows and advanced techniques like Perturb-seq and CRISPR ...
Investing21d
Illumina and Broad Clinical Labs enhance single-cell research
The collaboration combines Illumina's Single Cell Prep and NovaSeq™ X Plus platform with Broad Clinical Labs' expertise in high-throughput workflows and advanced techniques like Perturb-seq and ...